Description
An endogenous glucosylceramide; PLA2 type XIIA knockdown increases expression in rat brain; increased in the brain, but not the liver or spinal cord, of mice fed a methionine-restricted diet; plasma levels increase during exercise and return to basal levels during recovery in human athletes; product contains C22 glucosylceramide isolated from bovine buttermilk
Formal name: N-[(1S,2R,3E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]-docosanamide
Synonyms: C22 Glucosylceramide|GluCer(18:1/22:0)|Glucosylceramide (d18:1/22:0|N-C22:0-Glucocerebroside|N-Docosanoyl-glucopsychosine|N-Docosanoyl-β-glucosylsphingosine
Molecular weight: 784.2
CAS: 119242-44-3
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience